Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jare.2020.08.002 http://scihub22266oqcxt.onion/10.1016/j.jare.2020.08.002 32837738!7406419!32837738     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Adv+Res 2020 ; 26 (ä): 149-159 Nephropedia Template TP {{tp|p=32837738|t=2020. Molecular diagnostic technologies for COVID-19: Limitations and challenges |pdf=|usr=}}{{32837738}} gab.com Text Molecular diagnostic technologies for COVID-19: Limitations and challenges JO: J Adv Res http://www.kidney.de/pget.php?&tw=1&pmid=32837738 #FOAvip BACKGROUND: To curb the spread of the COVID-19 (coronavirus disease 2019) pandemic, the world needs diagnostic systems capable of rapid detection and quantification of the novel coronavirus (SARS-CoV-2). Many biomedical companies are rising to the challenge and developing COVID-19 diagnostics. In the last few months, some of these diagnostics have become commercially available for healthcare workers and clinical laboratories. However, the diagnostic technologies have specific limitations and reported several false-positive and false-negative cases, especially during the early stages of infection. AIM: This article aims to review recent developments in the field of COVID-19 diagnostics based on molecular technologies and analyze their clinical performance data. KEY CONCEPTS: The literature survey and performance-based analysis of the commercial and pre-commercial molecular diagnostics address several questions and issues related to the limitations of current technologies and highlight future research and development challenges to enable timely, rapid, low-cost, and accurate diagnosis of emerging infectious diseases. Twit Text FOAVip Molecular diagnostic technologies for COVID-19: Limitations and challenges ????J Adv Res http://www.kidney.de/pget.php?&tw=1&pmid=32837738 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32837738 #FOAvip English Wikipedia <ref>{{Cite pmid|32837738}}</ref> Molecular diagnostic technologies for COVID-19: Limitations and challenges #MMPMID32837738 Afzal A J Adv Res 2020[Nov]; 26 (ä): 149-159 PMID32837738show ga BACKGROUND: To curb the spread of the COVID-19 (coronavirus disease 2019) pandemic, the world needs diagnostic systems capable of rapid detection and quantification of the novel coronavirus (SARS-CoV-2). Many biomedical companies are rising to the challenge and developing COVID-19 diagnostics. In the last few months, some of these diagnostics have become commercially available for healthcare workers and clinical laboratories. However, the diagnostic technologies have specific limitations and reported several false-positive and false-negative cases, especially during the early stages of infection. AIM: This article aims to review recent developments in the field of COVID-19 diagnostics based on molecular technologies and analyze their clinical performance data. KEY CONCEPTS: The literature survey and performance-based analysis of the commercial and pre-commercial molecular diagnostics address several questions and issues related to the limitations of current technologies and highlight future research and development challenges to enable timely, rapid, low-cost, and accurate diagnosis of emerging infectious diseases. äMolecular diagnostic technologies for COVID-19: Limitations and challe(epmc).pdf DeepDyve Pubget Overpricing